Literature DB >> 23392846

Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastoma.

Huailei Liu1, Dayong Han, Yaohua Liu, Xu Hou, Jianing Wu, Huadong Li, Jie Yang, Chen Shen, Guang Yang, Changyu Fu, Xianfeng Li, Hui Che, Jing Ai, Shiguang Zhao.   

Abstract

Harmine hydrochloride (Har-hc), a derivative from Harmine which is a natural extractive from plants, has been considered for treatment of kinds of cancers and cerebral diseases. In this study, we found that Har-hc clearly decreased cell viability, induced apoptosis and inhibited Akt phosphorylation in glioblastoma cell lines. Moreover, Har-hc had the ability to inhibit self-renewal and promote differentiation of glioblastoma stem like cells (GSLCs) accompanied by inhibition of Akt phosphorylation. Especially, we demonstrated that Har-hc inhibited neurosphere formation of human primary GSLCs. In vivo test also confirmed Har-hc decreased the tumorigenicity of GSLCs. Thus we conclude that Har-hc has potent anti-cancer effects in glioblastoma cells, which is at least partially via inhibition of Akt phosphorylation. Administration of Har-hc may act as a new approach to glioblastoma treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392846     DOI: 10.1007/s11060-012-1034-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  46 in total

1.  Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.

Authors:  Candace A Gilbert; Marie-Claire Daou; Richard P Moser; Alonzo H Ross
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

Review 2.  Arsenic trioxide - An old drug rediscovered.

Authors:  Ashkan Emadi; Steven D Gore
Journal:  Blood Rev       Date:  2010-05-15       Impact factor: 8.250

3.  Akt signaling pathway: a target for radiosensitizing human malignant glioma.

Authors:  Emmanuel Chautard; Gaëlle Loubeau; Andreï Tchirkov; Jacques Chassagne; Claudine Vermot-Desroches; Laurent Morel; Pierre Verrelle
Journal:  Neuro Oncol       Date:  2010-02-04       Impact factor: 12.300

Review 4.  Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic.

Authors:  Shile Huang; Peter J Houghton
Journal:  Curr Opin Investig Drugs       Date:  2002-02

5.  Higher pAkt expression predicts a significant worse prognosis in glioblastomas.

Authors:  Yoshiyuki Suzuki; Katsuyuki Shirai; Kuniyuki Oka; Abdulelah Mobaraki; Yukari Yoshida; Shin-ei Noda; Masahiko Okamoto; Yoshihiko Suzuki; Jun Itoh; Hideaki Itoh; Shogo Ishiuchi; Takashi Nakano
Journal:  J Radiat Res       Date:  2010-04-12       Impact factor: 2.724

6.  Detection of cancer stem cells from the C6 glioma cell line.

Authors:  X-D Zhou; X-Y Wang; F-J Qu; Y-H Zhong; X-D Lu; P Zhao; D-H Wang; Q-B Huang; L Zhang; X-G Li
Journal:  J Int Med Res       Date:  2009 Mar-Apr       Impact factor: 1.671

7.  Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells.

Authors:  Gary L Gallia; Betty M Tyler; Christine L Hann; I-Mei Siu; Vincent L Giranda; Angelo L Vescovi; Henry Brem; Gregory J Riggins
Journal:  Mol Cancer Ther       Date:  2009-02-10       Impact factor: 6.261

8.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

9.  A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial.

Authors:  M Knowling; M Blackstein; R Tozer; V Bramwell; J Dancey; N Dore; S Matthews; E Eisenhauer
Journal:  Invest New Drugs       Date:  2006-09       Impact factor: 3.850

10.  Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus.

Authors:  Gislaine Z Réus; Roberto B Stringari; Bruna de Souza; Fabrícia Petronilho; Felipe Dal-Pizzol; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  Oxid Med Cell Longev       Date:  2010-09-01       Impact factor: 6.543

View more
  10 in total

1.  MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.

Authors:  Huailei Liu; Chenguang Li; Chen Shen; Fei Yin; Kaikai Wang; Yaohua Liu; Bingjie Zheng; Weiguang Zhang; Xu Hou; Xin Chen; Jianing Wu; Xiaoxiong Wang; Chen Zhong; Jiakang Zhang; Huaizhang Shi; Jing Ai; Shiguang Zhao
Journal:  J Neurooncol       Date:  2015-02-27       Impact factor: 4.130

Review 2.  Cancer stem cells and chemoresistance: The smartest survives the raid.

Authors:  Jihe Zhao
Journal:  Pharmacol Ther       Date:  2016-02-17       Impact factor: 12.310

Review 3.  Harnessing the apoptotic programs in cancer stem-like cells.

Authors:  Ying-Hua Wang; David T Scadden
Journal:  EMBO Rep       Date:  2015-08-07       Impact factor: 8.807

4.  Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.

Authors:  Michael Tarpley; Helen O Oladapo; Dillon Strepay; Thomas B Caligan; Lhoucine Chdid; Hassan Shehata; Jose R Roques; Rhashad Thomas; Christopher P Laudeman; Rob U Onyenwoke; David B Darr; Kevin P Williams
Journal:  Eur J Pharm Sci       Date:  2021-03-27       Impact factor: 5.112

5.  Potential Antitumor Effect of Harmine in the Treatment of Thyroid Cancer.

Authors:  Shu Ruan; Feng Jia; Jianbo Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-08       Impact factor: 2.629

6.  Harmine suppresses hyper-activated Ras-MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans.

Authors:  Jiaojiao Ji; Jiang Yuan; Xiaoyu Guo; Ruifang Ji; Qinghua Quan; Mei Ding; Xia Li; Yonggang Liu
Journal:  Cancer Cell Int       Date:  2019-06-11       Impact factor: 5.722

7.  Acetyl-11-keto-β-boswellic acid inhibits proliferation and induces apoptosis of gastric cancer cells through the phosphatase and tensin homolog /Akt/ cyclooxygenase-2 signaling pathway.

Authors:  Meng-Xue Sun; Xiao-Pu He; Pei-Yun Huang; Qi Qi; Wei-Hao Sun; Gao-Shuang Liu; Jie Hua
Journal:  World J Gastroenterol       Date:  2020-10-14       Impact factor: 5.742

Review 8.  Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives.

Authors:  Ana Laura V Alves; Izabela N F Gomes; Adriana C Carloni; Marcela N Rosa; Luciane S da Silva; Adriane F Evangelista; Rui Manuel Reis; Viviane Aline O Silva
Journal:  Stem Cell Res Ther       Date:  2021-03-24       Impact factor: 6.832

9.  Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways.

Authors:  Chae Won Ock; Gi Dae Kim
Journal:  Molecules       Date:  2021-11-05       Impact factor: 4.411

10.  Harmine Hydrochloride Triggers G2/M Cell Cycle Arrest and Apoptosis in HCT116 Cells through ERK and PI3K/AKT/mTOR Signaling Pathways.

Authors:  Gi Dae Kim
Journal:  Prev Nutr Food Sci       Date:  2021-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.